• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases
      • All News Releases
      • All Public Company
      • English-only


      • News Releases Overview
      • Multimedia Gallery
      • All Multimedia
      • All Photos
      • All Videos


      • Multimedia Gallery Overview
      • Trending Topics
      • All Trending Topics


  • Business & Money
      • Auto & Transportation
      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation


      • Auto & Transportation Overview
      • Business Technology
      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors


      • Business Technology Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Financial Services & Investing
      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Stock Offering
      • Stock Split
      • Venture Capital


      • Financial Services & Investing Overview
      • General Business
      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News


      • General Business Overview
  • Science & Tech
      • Consumer Technology
      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications


      • Consumer Technology Overview
      • Energy & Natural Resources
      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities


      • Energy & Natural Resources Overview
      • Environ­ment
      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters


      • Environ­ment Overview
      • Heavy Industry & Manufacturing
      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco


      • Heavy Industry & Manufacturing Overview
      • Telecomm­unications
      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications


      • Telecomm­unications Overview
  • Lifestyle & Health
      • Consumer Products & Retail
      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys


      • Consumer Products & Retail Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television


      • Entertain­ment & Media Overview
      • Health
      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine


      • Health Overview
      • Sports
      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories


      • Sports Overview
      • Travel
      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry


      • Travel Overview
  • Policy & Public Interest
      • Policy & Public Interest
      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy


      • Policy & Public Interest Overview
  • People & Culture
      • People & Culture
      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women


      • People & Culture Overview
      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO

      Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Policy & Public Interest
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • People & Culture
    • People & Culture
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2015

First quarter revenues rose 4 percent to $738 million; net earnings per diluted share were $0.92, including a $0.07 per diluted share restructuring charge; company maintaining annual earnings guidance despite significant currency headwinds


News provided by

Varian Medical Systems

Jan 28, 2015, 04:03 ET

Share this article

Share this article


PALO ALTO, Calif., Jan. 28, 2015 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR) today is reporting net earnings of $0.92 per diluted share in the first quarter of fiscal year 2015, including an $11 million or $0.07 per diluted share restructuring charge.  Varian's company-wide revenues totaled $738 million for the first quarter of fiscal year 2015, up 4 percent from the year-ago quarter.  The company ended the first quarter with a $3.1 billion backlog, up 13 percent from the end of the first quarter of fiscal year 2014.

"The company came in significantly ahead of its earnings target for the quarter with the help of favorable geographic and product mix, as well as successful cost containment initiatives that led to improved gross margins in all our businesses," said Dow R. Wilson, CEO of Varian Medical Systems. 

The company finished the first quarter of fiscal year 2015 with $904 million in cash and cash equivalents and $525 million of debt.  Cash flow from operations for the first quarter was $79 million.  During the first quarter of fiscal year 2015, the company spent $126 million to repurchase approximately 1.5 million shares of common stock.

Oncology Systems

Oncology Systems' first quarter revenues totaled $563 million, up 4 percent from the same quarter of fiscal year 2014.  First-quarter Oncology gross orders were $562 million, up 5 percent versus the year-ago quarter.  Consistent with the recent geographic reorganization of the Oncology Systems business, the company has consolidated the "Rest of World" region into three geographic regions – the Americas, APAC and EMEA.  It is now reporting results for each of these regions.  Oncology gross orders rose 17 percent in APAC, gained 12 percent in EMEA and declined by 2 percent in the Americas.  Gross orders in North America fell by 3 percent versus strong growth of 13 percent in the prior-year quarter. (A quarterly recast of gross orders and revenues for fiscal years 2013 and 2014 in each of the reclassified geographic regions is attached.)

"Oncology revenues and gross margins were strong with the help of good performance in North America as well as robust gains in our software and service product lines," said Wilson.  "International gross order growth in this business was driven by strong performance in emerging markets, particularly in China."

Imaging Components

First quarter revenues for Imaging Components were $166 million, up 3 percent from the year-ago quarter while first quarter gross orders increased by 34 percent to $163 million versus a weak year-ago quarter when orders declined.

"Demand for our flat panels and tubes drove the strong order growth in Imaging Components and kept the business on track to achieve long-term high single-digit order growth," said Wilson.

Other

The company's Other category, including the Varian Particle Therapy business and the Ginzton Technology Center, recorded revenues of $9 million and gross orders of $1 million in the quarter. 

Outlook

"The company got off to a good start in the first quarter of fiscal 2015 with revenues and earnings coming in ahead of expectations," said Wilson.  "Our outlook for the full fiscal year is heavily impacted by the recent dramatic swing in currency exchange rates which we believe will significantly reduce revenues and earnings in the balance of the year.  We now believe that total company revenues for fiscal year 2015 could increase by about 5 percent.  With the earnings momentum of the first quarter, we believe that we can maintain our prior guidance of $4.16 to $4.26 per diluted share for the fiscal year. 

"Given current exchange rates and the expected timing of shipments in the year, we believe total company revenues for the second quarter should increase by about 2 percent versus the year-ago period.  Net earnings per diluted share for the second quarter could be in the range of $0.98 to $1.02."

The guidance excludes contracted proton projects that are not yet financed or booked into backlog.  If these projects are booked during the fiscal year, the potential upside in revenues and profits could be significant.

Investor Conference Call

Varian Medical Systems is scheduled to conduct its first quarter fiscal year 2015 conference call at 2 p.m. PT today.  To hear a live webcast or replay of the call, visit the investor relations page on the company's web site at www.varian.com/investor where it will be archived for a year.  To access the call via telephone, dial 1-877-869-3847 from inside the U.S. or 1-201-689-8261 from outside the U.S.  The replay can be accessed by dialing 1-877-660-6853 from inside the U.S. or 1-201-612-7415 from outside the U.S. and entering confirmation code 13597116.  The telephone replay will be available through 5 p.m. PT, Friday, January 30, 2015.

Varian Medical Systems, Inc., of Palo Alto, California, focuses energy on saving lives by equipping the world with advanced technology for fighting cancer and for X-ray imaging.  The company is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is also a premier supplier of X-ray imaging components, including tubes, digital detectors, and image processing software and workstations for use in medical, scientific, and industrial settings, as well as for security and non-destructive testing.  Varian Medical Systems employs approximately 6,800 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world.  For more information, visit http://www.varian.com or follow us on Twitter.

Forward-Looking Statements

Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning industry or market outlook, including growth drivers; the company's future orders, revenues, or earnings growth or other financial results; and any statements using the terms "anticipate," "believe," "expect," "outlook," "could," or similar statements are forward-looking statements that involve risks and uncertainties that could cause the company's actual results to differ materially from those anticipated. Such risks and uncertainties include global economic conditions; currency exchange rates and tax rates; the impact of  the Affordable Health Care for America Act (including excise taxes on medical devices) and any further healthcare reforms (including changes to Medicare and Medicaid), and/or changes in third-party reimbursement levels; demand for the company's products; the company's ability to develop, commercialize and deploy new products; the company's ability to meet Food and Drug Administration (FDA) and other regulatory requirements for product clearances or to comply with FDA and other regulatory regulations or procedures; changes in the regulatory environment, including with respect to FDA requirements; the company's assessment of the goodwill associated with its particle therapy business; challenges associated with the successful commercialization of the company's particle therapy business; the effect of adverse publicity; the company's reliance on sole or limited-source suppliers; the impact of reduced or limited demand by purchasers of certain X-ray products; the company's ability to maintain or increase margins; the impact of competitive products and pricing; the potential loss of key distributors or key personnel; challenges to public tender awards and the loss of such awards or other orders; and the other risks listed from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein. The company assumes no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

FOR INFORMATION CONTACT:

Elisha Finney (650) 424-6803
[email protected]

Spencer Sias (650) 424-5782
[email protected]

A summary of earnings and other financial information follows.

Varian Medical Systems, Inc. and Subsidiaries
Consolidated Statements of Earnings
(Unaudited)



(Dollars and shares in millions, except per share amounts)


Q1 QTR

2015



Q1 QTR

2014 (1)











Gross orders

$

725.8


$

655.4



  Oncology Systems


561.7



533.3



  Imaging Components


162.7



121.4



  Other


1.4



0.7











Order backlog

$

3,124.3


$

2,766.5











Revenues     

$

737.9


$

711.5



  Oncology Systems


563.3



541.4



  Imaging Components


166.0



161.2



  Other


8.6



8.9











Cost  of  revenues  

$

410.9


$

401.9











Gross margin  


327.0



309.6



  As a percent of revenues


44.3%



43.5%



 

Operating expenses  








  Research and development


57.1



58.0



  Selling, general and administrative 


140.4



109.6











Operating earnings


129.5



142.0



  As a percent of revenues


17.5%



20.0%











Interest income, net


0.9



0.4











Earnings before taxes


130.4



142.4











Taxes on earnings 


37.1



44.4











Net earnings   

$

93.3


$

98.0



 As a percent of revenues


12.6%



13.8%



























Net earnings per share – basic

$

0.93


$

0.92



Net earnings  per share – diluted

$

0.92


$

0.91











Shares used in the calculation of net earnings per share:








Average shares outstanding - basic


100.5



106.0



Average shares outstanding - diluted


101.6



107.4










(1)

 Prior period numbers have been recast to conform to the segment reporting change made in Q2, FY2014

Varian Medical Systems, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets






(In thousands)


January 2,  


September 26,

2015

     2014  (1)

(Unaudited)


Assets





Current assets:





    Cash and cash equivalents

$

904,359

$

849,275

    Short-term investment


68,522


66,176

    Accounts receivable, net


663,041


731,929

    Inventories                                       


630,872


572,261

    Deferred tax assets and other                                


285,571


274,524

Total current assets                                       


2,552,365


2,494,165






Property, plant and equipment                                            


786,226


775,972

    Accumulated depreciation and amortization                    


(450,901)


(437,973)

Property, plant and equipment, net                         


335,325


337,999






Goodwill


237,702


240,626

Other assets                                                   


270,910


284,500

Total assets                                              

$

3,396,302

$

3,357,290






Liabilities and Equity





Current liabilities:                                                      





    Accounts payable                                             

$

142,804

$

187,377

    Accrued expenses                                             


304,608


324,409

    Deferred revenues                                             


433,046


421,845

    Advance payments from customers                              


182,379


170,724

    Product warranty                                                        


44,093


47,299

    Short-term borrowings                              


100,000


-

    Current maturities of long-term debt                              


50,000


50,000

Total current liabilities                                  


1,256,930


1,201,654

Other long-term liabilities


146,470


151,716

Long-term debt                                                            


375,000


387,500

Total liabilities                                          


1,778,400


1,740,870






Equity:





Varian shareholders' equity:





    Common stock


100,327


100,942

    Capital in excess of par value


659,098


642,848

    Retained earnings and accumulated other comprehensive loss 


856,700


872,630

Total Varian shareholders' equity                                 


1,616,125


1,616,420

Non-controlling interest


1,777


-

Total Equity


1,617,902


1,616,420

Total liabilities and equity              

$

3,396,302

$

3,357,290

(1)

The condensed consolidated balance sheet as of September 26, 2014 was derived from audited financial statements as of that date. 




Varian Medical Systems, Inc. and Subsidiaries

Gross Orders and Revenues by Region Restated

(Unaudited)















Gross Orders



FY 2014






FY 2013



(in Millions)
















Q114

Q214

Q314

Q414

FY 2014



Q113

Q213

Q313

Q413

FY 2013

Oncology














Americas

$

281.0

290.5

305.0

492.9

1,369.4


$

252.1

271.9

299.1

422.0

1,245.1

EMEA


160.8

194.4

211.7

259.3

826.2



157.2

188.6

206.7

248.6

801.1

APAC


91.5

128.1

103.7

165.5

488.8



99.5

116.4

121.4

170.6

507.9

Total

$

533.3

613.0

620.4

917.7

2,684.4


$

508.8

576.9

627.2

841.2

2,554.1















North America

$

258.6

255.9

285.8

414.1

1,214.4


$

229.7

248.6

285.3

371.7

1,135.3

International

$

274.7

357.1

334.6

503.6

1,470.0


$

279.1

328.3

341.9

469.5

1,418.8















Imaging Components












Americas

$

35.6

66.1

59.9

60.5

222.1


$

58.3

36.8

57.3

62.5

214.9

EMEA


37.4

50.6

35.8

99.8

223.6



19.9

62.7

37.3

62.5

182.4

APAC


48.4

88.3

66.6

73.5

276.8



64.0

80.6

50.0

76.3

270.9

Total

$

121.4

205.0

162.3

233.8

722.5


$

142.2

180.1

144.6

201.3

668.2















North America

$

34.2

64.8

58.4

58.8

216.2


$

55.7

35.8

55.2

61.8

208.5

International

$

87.2

140.2

103.9

175.0

506.3


$

86.5

144.3

89.4

139.5

459.7

Revenues


FY 2014



FY 2013

(in Millions)
















Q114

Q214

Q314

Q414

FY 2014



Q113

Q213

Q313

Q413

FY 2013

Oncology














Americas

$

240.3

282.5

323.5

319.2

1,165.5


$

255.4

270.1

275.5

315.9

1,116.9

EMEA


189.5

157.9

163.8

189.9

701.1



155.3

177.7

169.2

160.5

662.7

APAC


111.6

162.7

90.9

112.4

477.6



113.6

134.0

116.6

108.9

473.1

 Total

$

541.4

603.1

578.2

621.5

2,344.2


$

524.3

581.8

561.3

585.3

2,252.7















North America

$

224.9

263.0

309.0

291.3

1,088.2


$

241.1

258.2

264.4

294.3

1,058.0

International

$

316.5

340.1

269.2

330.2

1,256.0


$

283.2

323.6

296.9

291.0

1,194.7















Imaging Components












Americas

$

57.0

54.1

53.5

65.3

229.9


$

55.9

62.4

50.2

55.4

223.9

EMEA


43.2

46.4

50.9

47.6

188.1



37.3

44.9

50.4

49.7

182.3

APAC


61.0

68.5

57.4

55.3

242.2



56.8

59.1

57.6

62.2

235.7

Total

$

161.2

169.0

161.8

168.2

660.2


$

150.0

166.4

158.2

167.3

641.9















North America

$

55.1

52.6

52.0

63.5

223.2


$

54.2

60.3

48.9

54.3

217.7

International

$

106.1

116.4

109.8

104.7

437.0


$

95.8

106.1

109.3

113.0

424.2

SOURCE Varian Medical Systems

Related Links

http://www.varian.com

Modal title

    Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

    Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

    About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement

    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom

    My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision


Products


About


My Services
  • All News Releases
  • Online Member Center
  • ProfNet℠
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2021 Cision US Inc.